Surgery Partners, Inc. (SGRY)
| Market Cap | 2.66B |
| Revenue (ttm) | 1.86B |
| Net Income (ttm) | -155.60M |
| Shares Out | 48.78M |
| EPS (ttm) | -3.19 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 19 |
| Last Price | $42.92 |
| Previous Close | $44.19 |
| Change ($) | -1.28 |
| Change (%) | -2.89% |
| Day's Open | 44.21 |
| Day's Range | 42.52 - 44.19 |
| Day's Volume | 157,111 |
| 52-Week Range | 8.41 - 47.02 |
BRENTWOOD, Tenn., April 06, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the ...
Surgery Partners (NASDAQ:SGRY) announces its next round of earnings this Wednesday, March 10. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4 earnings announcement.
BRENTWOOD, Tenn., March 01, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that Dr. Patrici...
BRENTWOOD, Tenn., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the C...
BRENTWOOD, Tenn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its previously announced underwritten public offering of 7,5...
BRENTWOOD, Tenn., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced that it has commenced an underwritten public offering of 6,000,000 shares o...
BRENTWOOD, Tenn., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (the “Company”) will be meeting with investors as part of the 2021 J.P. Morgan Healthcare Conference t...
BRENTWOOD, Tenn., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced...
Surgery Partners runs surgical hospitals and ambulatory surgery centres in partnership with physicians, handling the non-specialist side of the business. The company's share price hit a low of $4.3 in M...
Bear of the Day: Surgery Partners (SGRY)
Investors need to pay close attention to Surgery Partners (SGRY) stock based on the movements in the options market lately.
BRENTWOOD, Tenn., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced...
Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q3 2020 Results - Earnings Call Transcript
Surgery Partners (SGRY) delivered earnings and revenue surprises of -76.67% and 10.57%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Surgery Partners (NASDAQ:SGRY) decreased 0.3% in pre-market trading after the company reported Q3 results.
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BRENTWOOD, Tenn., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the C...
IRVING, Texas, Sept. 15, 2020 /PRNewswire/ -- NorthStar Anesthesia ("NorthStar" or the "Company"), one of the country's leading anesthesia care providers and managers, today announced that Anesthesia Co...
Surgery Partners, Inc.'s (SGRY) CEO Eric Evans on Q2 2020 Results - Earnings Call Transcript
Surgery Partners (SGRY) delivered earnings and revenue surprises of 5.88% and 1.22%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
BRENTWOOD, Tenn., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announc...
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BRENTWOOD, Tenn., July 24, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that its wholly-owned subsidiary, Surgery Center Holdings...
BRENTWOOD, Tenn., July 21, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the...
Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q1 2020 Results - Earnings Call Transcript
Surgery Partners (SGRY) delivered earnings and revenue surprises of 41.38% and 16.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q4 2019 Results - Earnings Call Transcript
Surgery Partners (SGRY) delivered earnings and revenue surprises of -16.67% and 2.60%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Does Surgery Partners (SGRY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wayne S. DeVeydt appointed to Executive Chairman of the Board Eric Evans appointed to Chief Executive Officer Company reaffirms 2019 full year guidance of double-digit Adjusted EBITDA growth
Zendesk (ZEN), Surgery Partners (SGRY) and Tesla (TSLA) Are Aggressive Growth Stocks
A look a three names on your aggressive growth stock radar screen.
Surgery Partners is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
As of late, it has definitely been a great time to be an investor in Surgery Partners.
Surgery Partners, Inc. (SGRY) CEO Wayne DeVeydt on Q3 2019 Results - Earnings Call Transcript
EVP & COO of Surgery Partners Inc (30-Year Financial, Insider Trades) Jason Eric Evans (insider trades) bought 25,000 shares of SGRY on 08/20/2019 at an average price of $5.95 a share.
Surgery Partners, Inc. (SGRY) CEO Wayne DeVeydt on Q2 2019 Results - Earnings Call Transcript
Surgery Partners (SGRY) delivered earnings and revenue surprises of -70.59% and -0.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Surgery Partners, Inc. (SGRY) CEO Wayne DeVeydt on Q1 2019 Results - Earnings Call Transcript
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
About SGRY
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, suc... [Read more...]
| Industry Medical Care Facilities | IPO Date Oct 1, 2015 |
| CEO J. Eric Evans | Employees 9,100 |
| Stock Exchange NASDAQ | Ticker Symbol SGRY |
Financial Performance
In 2020, SGRY's revenue was $1.86 billion, an increase of 1.57% compared to the previous year's $1.83 billion. Losses were -$116.10 million, 55.2% more than in 2019.
Analyst Forecasts
According to 6 analysts, the average rating for SGRY stock is "Buy." The 12-month stock price forecast is 51.80, which is an increase of 20.70% from the latest price.